Clinical Trial Update: An Exploratory Study on the Safety and Effectiveness of Paliperidone in Patients With Schizophrenia [Phase 2]

View source ↗

Summary

A Phase 2 exploratory study evaluating the safety and effectiveness of paliperidone in patients with schizophrenia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• PALIPERIDONE (paliperidone)

Snippet

Sponsor: Janssen Pharmaceutical K.K. | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED